Article
Surgery
Jennifer K. Plichta, Samantha M. Thomas, Amanda R. Sergesketter, Rachel A. Greenup, Laura H. Rosenberger, Oluwadamilola M. Fayanju, Gretchen Kimmick, Jeremy Force, Terry Hyslop, E. Shelley Hwang
Summary: This study aimed to identify prognostic groups within a de novo metastatic breast cancer cohort by incorporating both anatomic and biologic factors. Results showed that stratifying patients based on these factors led to reliable and reproducible prognostic estimates, supporting the formal classification of de novo stage IV breast cancer into three distinct prognosis groups.
Article
Oncology
Chen-Lu Lian, Hai-Yan Zhang, Jun Wang, Jian Lei, Li Hua, Yong-Xiong Chen, San-Gang Wu
Summary: The study validated the applicability of the 8th AJCC pathological prognostic staging system for breast cancer patients with internal mammary lymph nodes metastasis, showing improved prognostic stratification and better prediction of prognosis for this specific subgroup of breast cancer patients.
FRONTIERS IN ONCOLOGY
(2021)
Article
Medicine, General & Internal
Dan Jiang, Tarjei S. Hveem, Mark Glaire, David N. Church, David J. Kerr, Li Yang, Havard E. Danielsen
Summary: This study demonstrates the prognostic value of combined T-lymphocyte and stroma fractions in early colorectal cancer. Low stroma fraction and high stroma fraction can identify low-risk and high-risk subgroups, respectively, providing valuable guidance for patient treatment strategies.
Article
Oncology
Huapyong Kang, Seung-seob Kim, Min Je Sung, Jung Hyun Jo, Hee Seung Lee, Moon Jae Chung, Jeong Youp Park, Seung Woo Park, Si Young Song, Mi-Suk Park, Seungmin Bang
Summary: The suitability of the 8th edition AJCC staging system for clinical staging of pancreatic cancer remains uncertain. This study validated the prognostic performance and suitability of the current staging system and found that it is not validated for clinical staging. Separate criteria more suitable for clinical staging should be considered.
Article
Oncology
Chen-Lu Lian, Guan-Qiao Li, Ping Zhou, Jun Wang, Zhen-Yu He, San-Gang Wu
Summary: The study investigated the impact of the 8th American Joint Committee on Cancer (AJCC) pathological prognostic staging on chemotherapy decision-making for T1-2N0M0 triple-negative breast cancer (TNBC) patients. The new AJCC staging system did not show superior discriminatory ability over the 7th AJCC staging system but could more accurately predict chemotherapy benefit, potentially enabling more patients to avoid unnecessary chemotherapy.
Article
Medicine, General & Internal
Timothy J. Whelan, Sally Smith, Sameer Parpia, Anthony W. Fyles, Anita Bane, Fei-Fei Liu, Eileen Rakovitch, Lynn Chang, Christiaan Stevens, Julie Bowen, Sawyna Provencher, Valerie Theberge, Anna Marie Mulligan, Zuzana Kos, Mohamed A. Akra, K. David Voduc, Tarek Hijal, Ian S. Dayes, Gregory Pond, James R. Wright, Torsten O. Nielsen, Mark N. Levine
Summary: Among women with T1N0 grade 1 or 2 luminal A breast cancer who had undergone breast-conserving surgery and received endocrine therapy, the incidence of local recurrence at 5 years was low without radiotherapy.
NEW ENGLAND JOURNAL OF MEDICINE
(2023)
Article
Spectroscopy
Baoping Zhang, Zhanqin Zhang, Bingran Gao, Furong Zhang, Lu Tian, Haishan Zeng, Shuang Wang
Summary: This study conducted a spectral histopathological analysis to connect Raman micro spectroscopy with the breast cancer TNM system. By evaluating the spectral variations and establishing a GDA pathological diagnostic model, the study successfully discriminated different TNM stages and grades of breast cancer. Micro-Raman images were reconstructed using K-means clustering analysis, allowing for visualization of structural differences between healthy tissue and breast cancer tissue. Univariate imaging techniques were used to describe the distribution differences of biochemical components in the scanned regions.
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
(2023)
Article
Oncology
Olga Kantor, Alison Laws, Ricardo G. Pastorello, Claire King, Stephanie Wong, Tanujit Dey, Stuart Schnitt, Tari A. King, Elizabeth A. Mittendorf
Summary: This study compared the performance of different staging systems in breast cancer patients after neoadjuvant chemotherapy and found that AJCC pathologic prognostic staging and RCB had better discrimination for disease-free survival and overall survival compared to the Neo-Bioscore. Results validate the ability of these staging systems to stratify survival outcomes in NAC patients, with best discrimination achieved using AJCC pathologic prognostic stage or RCB.
ANNALS OF SURGICAL ONCOLOGY
(2021)
Article
Oncology
Jose Pablo Leone, Michael J. Hassett, Julieta Leone, Sara M. Tolaney, Carlos T. Vallejo, Bernardo A. Leone, Eric P. Winer, Nancy U. Lin
Summary: This study compares the proportions of pathologic complete response (pCR) between male breast cancer (MaBC) and female breast cancer (FBC) in neoadjuvant chemotherapy (NAC), and finds that FBC has higher pCR rates. Furthermore, pCR is associated with survival rates in both MaBC and FBC.
Article
Oncology
Jennifer K. Plichta, Samantha M. Thomas, Daniel F. Hayes, Mariana Chavez-MacGregor, Kimberly Allison, Jennifer de los Santos, Amy M. Fowler, Armando E. Giuliano, Priyanka Sharma, Benjamin D. Smith, Elizabeth van Eycken, Stephen B. Edge, Gabriel N. Hortobagyi
Summary: This study developed a staging system for patients with metastatic cancer at the time of initial diagnosis, aimed at improving prognostic estimates. The heterogeneity in outcomes for metastatic breast cancer patients could guide future revisions of staging guidelines for newly diagnosed stage IV disease.
JOURNAL OF CLINICAL ONCOLOGY
(2023)
Article
Public, Environmental & Occupational Health
Xianghui Yang, Liyong Deng, Min Li, Yongjie Zhou, Guihua Wang
Summary: This study evaluated the association between socioeconomic status (SES) factors and cancer-specific survival (CSS) in patients with non-small cell lung cancer (NSCLC). A novel TNM-SES staging system was proposed, which showed superior predictive value compared to the traditional TNM stage.
FRONTIERS IN PUBLIC HEALTH
(2022)
Article
Biochemistry & Molecular Biology
Kamil Demircan, Qian Sun, Ylva Bengtsson, Petra Seemann, Johan Vallon-Christersson, Martin Malmberg, Lao H. Saal, Lisa Ryd, Waldemar B. Minich, Ake Borg, Jonas Manjer, Lutz Schomburg
Summary: The presence of SELENOP autoantibodies in breast cancer patients is associated with poor prognosis, particularly in patients with low selenium levels. These autoantibodies may disrupt the transport function of SELENOP, leading to an increased risk of recurrence and mortality.
Article
Biology
Ying Su, Xuecong Tian, Rui Gao, Wenjia Guo, Cheng Chen, Chen Chen, Dongfang Jia, Hongtao Li, Xiaoyi Lv
Summary: This study used gene expression profiling data to diagnose and stage colon cancer, and identified eight genes associated with colon cancer prognosis using protein-protein interaction network analysis. The RF model showed excellent performance in diagnosis and staging, achieving high accuracy and recall rates.
COMPUTERS IN BIOLOGY AND MEDICINE
(2022)
Article
Oncology
Miaoquan Zhang, Chao Ding, Lin Xu, Biyi Ou, Shoucheng Feng, Guoqiang Wang, Wei Wang, Yao Liang, Yingbo Chen, Zhiwei Zhou, Haibo Qiu
Summary: By evaluating the prognostic value of lymph node ratio (LNR) and establishing a novel tumor-ratio-metastasis (TRM) staging system, the study demonstrated improved homogeneity and discriminatory ability in predicting the prognosis of gastric cancer patients compared with the AJCC TNM staging system.
FRONTIERS IN ONCOLOGY
(2021)
Article
Biochemistry & Molecular Biology
Kun Li, Guangqing Tan, Xin Zhang, Weiyu Lu, Jingyi Ren, Yuewen Si, Enoch Appiah Adu-Gyamfi, Fangfang Li, Yingxiong Wang, Biao Xie, Meijiao Wang
Summary: EIF4G1 is identified as a potential prognostic biomarker and therapeutic target for breast cancer, as it may regulate the tumor microenvironment and affect metastasis and overall survival in breast cancer patients.
Article
Surgery
Marguerite M. Rooney, Krislyn N. Miller, Jennifer K. Plichta
SURGICAL CLINICS OF NORTH AMERICA
(2023)
Article
Anesthesiology
H. S. Tan, J. K. Plichta, A. Kong, C. W. Tan, S. Hwang, R. Sultana, M. C. Wright, A. T. H. Sia, B. L. Sng, A. S. Habib
Summary: Identifying factors associated with persistent pain after breast cancer surgery may facilitate risk stratification and individualised management. In this multicenter study, a predictive model was developed from a sample of Asian and American women. The independent risk factors for persistent pain after surgery were found to be age, diabetes, pre-operative pain score at sites other than the breast, previous mastitis, and perceived stress scale.
Article
Oncology
Jennifer K. K. Plichta, Mahsa Taskindoust, Rachel A. A. Greenup
Summary: The benefits of surgical resection of the primary tumor in individuals with metastatic breast cancer remain controversial, with conflicting findings from retrospective and prospective studies. While some retrospective studies suggest a potential survival benefit, recent randomized controlled trials challenge these findings. Prospective studies indicate that most patients with metastatic breast cancer are unlikely to experience a survival benefit from surgery.
CURRENT BREAST CANCER REPORTS
(2023)
Editorial Material
Oncology
Sydney M. Record, Jennifer K. Plichta
ANNALS OF SURGICAL ONCOLOGY
(2023)
Article
Oncology
Jennifer K. Plichta, Samantha M. Thomas, Daniel F. Hayes, Mariana Chavez-MacGregor, Kimberly Allison, Jennifer de los Santos, Amy M. Fowler, Armando E. Giuliano, Priyanka Sharma, Benjamin D. Smith, Elizabeth van Eycken, Stephen B. Edge, Gabriel N. Hortobagyi
Summary: This study developed a staging system for patients with metastatic cancer at the time of initial diagnosis, aimed at improving prognostic estimates. The heterogeneity in outcomes for metastatic breast cancer patients could guide future revisions of staging guidelines for newly diagnosed stage IV disease.
JOURNAL OF CLINICAL ONCOLOGY
(2023)
Article
Oncology
Krislyn N. Miller, Samantha M. Thomas, Sydney M. Record, Laura H. Rosenberger, Maggie L. DiNome, Gayle DiLalla, Jeremy M. Force, E. Shelley Hwang, Jennifer K. Plichta
Summary: This study examines the impact of age on pathologic complete response (pCR) rates and overall survival (OS) in women with estrogen receptor-positive (ER+) breast cancer after neoadjuvant therapy. The results indicate that older women have lower rates of pCR in the breast or lymph nodes after neoadjuvant chemotherapy, but age has less impact on pCR rates after neoadjuvant endocrine therapy. Importantly, achieving pCR after endocrine therapy is associated with improved OS in older women.
ANNALS OF SURGICAL ONCOLOGY
(2023)
Article
Oncology
Therese B. Bevers, Bethany L. Niell, Jennifer L. Baker, Debbie L. Bennett, Ermelinda Bonaccio, Melissa S. Camp, Sona Chikarmane, Emily F. Conant, Mohammad Eghtedari, Meghan R. Flanagan, Jeffrey Hawley, Mark Helvie, Linda Hodgkiss, Tamarya L. Hoyt, Jennifer Ivanovich, Maxine S. Jochelson, Swati Kulkarni, Rachael B. Lancaster, Caitlin Mauer, Jessica Maxwell, Bhavika K. Patel, Mark Pearlman, Liane Philpotts, Donna Plecha, Jennifer K. Plichta, Shadi Shakeri, Mary Lou Smith, Clarie L. Streibert, Roberta M. Strigel, Lusine Tumyan, Nicole S. Winkler, Dulcy E. Wolverton, Mary Anne Bergman, Rashmi Kumar, Katie Stehman
Summary: The NCCN Guidelines for Breast Cancer Screening and Diagnosis provide a practical framework for healthcare providers to screen and evaluate clinical presentations and breast lesions. The expert panel from various disciplines meets regularly to review emerging data and update the recommendations.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
(2023)
Meeting Abstract
Oncology
Astrid Botty van den Bruele, Morgan Paul, Samantha M. Thomas, Sarah L. Sammons, Maggie L. DiNome, Jennifer K. Plichta, Akiko Chiba, Laura H. Rosenberger, E. Shelley Hwang
Meeting Abstract
Oncology
Hannah E. Woriax, Samantha M. Thomas, Jennifer K. Plichta, Laura H. Rosenberger, Astrid Botty van de Bruele, Akiko Chiba, Gayle DiLalla, Carolyn Menendez, E. Shelley Hwang, Maggie L. DiNome
Meeting Abstract
Oncology
Amanda Nash, Diane Bloom, Stephanie Wheeler, Kandace McGuire, Clara Lee, Kevin Weinfurt, Donald Rosenstein, Jennifer Plichta, Julie Jacobson Vann, E. Shelley Hwang
ANNALS OF SURGICAL ONCOLOGY
(2023)
Meeting Abstract
Oncology
Kendra Modell Parrish, Samantha Thomas, Astrid Botty van den Bruele, Gayle DiLalla, Maggie DiNome, Carolyn Menendez, Jeremy Force, Laura Rosenberger, Hannah Woriax, E. Shelley Hwang, Jennifer Plichta, Akiko Chiba
ANNALS OF SURGICAL ONCOLOGY
(2023)
Meeting Abstract
Oncology
Kendra Modell Parrish, Samantha Thomas, Astrid Botty van den Bruele, Gayle DiLalla, Maggie DiNome, Carolyn Menendez, Laura Rosenberger, E. Shelley Hwang, Jennifer Plichta, Akiko Chiba, Hannah Woriax
ANNALS OF SURGICAL ONCOLOGY
(2023)
Meeting Abstract
Oncology
Sydney Record, Samantha Thomas, Astrid Botty van den Bruele, Akiko Chiba, Gayle DiLalla, Maggie DiNome, Gretchen Kimmick, Laura Rosenberger, Hannah Woriax, E. Shelley Hwang, Jennifer Plichta
ANNALS OF SURGICAL ONCOLOGY
(2023)
Meeting Abstract
Surgery
Laura Noteware, Yi Ren, Amanda Nash, Jennifer K. Plichta, Laura H. Rosenberger, Astrid Botty Van den Bruele, Eun-Sil (Shelley) Hwang
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
(2023)
Article
Oncology
Huiyue Li, Jennifer K. Plichta, Kan Li, Yizi Jin, Samantha M. Thomas, Fei Ma, Li Tang, Qingyi Wei, You-Wen He, Qichen Chen, Yuanyuan Guo, Yueping Liu, Jian Zhang, Sheng Luo
Summary: In both early-stage HR-positive and TNBC patients, HER2-low status was associated with lower pCR rates. HER2-zero status might be considered an adverse prognostic factor for OS in patients not achieving pCR.
BREAST CANCER RESEARCH AND TREATMENT
(2023)